PROVIDENCE – A Cambridge, Mass.-based biotech company may build a $155 million pharmaceutical manufacturing facility in Rhode Island, and is seeking state incentives from the R.I. Commerce Corp. The project put forward by Rubius Therapeutics Inc. is on the agenda for a subcommittee of the Commerce RI executive board Monday afternoon. The location of the…
Want More Free?
To access 2 more articles, please log in or register for free.
Registered users get access to a limited number of free articles every month.